| |
| |
| |
| » |
Preclinical Studies Home |
| --------------------------- |
| » |
|
| |
|
| |
|
| |
|
| |
Scientific Abstracts |
| » |
|
| ------------------------------ |
| » |
|
| ------------------------------ |
|
    |
| |
| |
| |
| PHY906 Preclinical Scientific Abstracts |
| |
* |
“A Phase I/II, Multi-center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 plus Capecitabine in Patients with Advanced Pancreatic Carcinoma” |
Muhammad Wasif Saif, Lynne Lamb, Nichole Grant, Maria Mezes, Shwu Huey Liu, Zaoli Jiang, Yung-Chi Cheng
(Submitted to clinical CRC journal 2007) |
|
| |
| * |
“PHY906 in Hepatocellular Carcinoma” |
Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Wing Lam, Min Ye, Yashang Lee, Duncan Liang, Susan Grill, Yun Yen, Michal Rose, Samuel So, Wasif Saif, Edward Chu, Robert Tilton and Yung-Chi Cheng
Proc. Am Assoc Cancer Res. 2007: #1841 |
|
| |
| * |
“Phase I/II Study of PHY906/Capecitabine in Hepatocellular Carcinoma” |
Michal Rose, Yun Yen, Samuel So, M.W. Saif, Edward Chu, Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Robert Tilton and Yung-Chi Cheng
Accepted by 2007 ASCO annual meeting) |
|
| |
| * |
“Synergistic Activity of PHY906 with Capecitabine in Pancreatic Carcinoma” |
M. W. Saif, S. Liu, A. Elfiky, Z. Jiang, Y. Cheng
Accepted by 2007 ASCO annual meeting |
|
| |
| * |
"PHY906 as a Broad-Spectrum Enhancer in Cancer Therapy: Clinical and Preclinical Results in Hepatocellular Carcinoma" |
Shwu-Huey Liu, Angeline Foo, Zaoli Jiang, Rajendra Marathe, Jing Guan, Tah-Mun Su, Robert Tilton, Yun Yen, Michal Rose, Samuel So, Edward Chu and Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2006: #2145 |
|
| |
| * |
"Dipropyloxy baicalein, a biochemical modulator in facilitating the oral uptake of drugs" |
Shwu-Huey Liu, Yashang Lee, Zaoli Jiang, Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2006: #2142 |
|
| |
| * |
"Polychemical Botanicals: The Future Of Medicine" |
Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Rajendra Marathe, Jing Guan, Tah-Mun Su, Robert Tilton, and Yung-Chi Cheng
Proceedings of the 11th SCBA International Symposium 2006 |
|
| |
| * |
“Preclinical Studies of PHY906 in Cancer Chemotherapy” |
Shwu-Huey Liu, Zaoli Jiang, Wing Lam, Min Ye, Yashang Lee, Duncan Liang, Susan Grill, Robert Tilton, and Yung-Chi Cheng
Proceedings of the Fifth Meeting of Consortium for Globalization of Chinese Medicine2006 |
|
| |
| |
“PHY906 in Advanced Colorectal and Hepatocellular Cancer Clinical Trials” |
Edward Chu, Yun Yen, Michal Rose, Samuel So, Shivanni Kumar, Wasif Saif, James J. Lee, Scott Wadler, Mark O’Rouke, Leslie R. Laufman, Shwu-Huey Liu and Yung-Chi Cheng
Proceedings of the Fifth Meeting of Consortium for Globalization of Chinese Medicine 2006 |
|
| |
| |
“Progress Towards a High Quality Metric for Botanical Quality Control” |
Jing Guan, Zaoli Jiang, Shwu-Huey Liu, Rajendra Marathe, Winfried van Eyndhoven, Hailong Wang, Robert Tilton, Yung-Chi Cheng
Proceedings of the Fifth Meeting of Consortium for Globalization of Chinese Medicine 2006 |
|
| |
|
“Seeking FDA Approval for a Botanical Prescription Drug: Case Study of PHY906” |
Shwu-Huey Liu, Zaoli Jiang, Tah-Mun Su, Robert Tilton, Edward Chu and Yung-Chi Cheng
Proceeding of “ 20th Natural Medicine Conference (2005) |
|
| |
|
“PHY906: Enhancement of Cancer Chemotherapeutic Agents and Insights into Mechanism of Action” |
Shwu-Huey Liu, Zaoli Jiang, Duncan Leung, Yashang Lee and Yung-Chi Cheng
Proceedings of “Medicine in the 21st Century Tri-Conference and Bio-Forum 2004, ” p. 77 (2004) |
|
|
|
“Developing PHY906 as a Broad- Spectrum Modulator of Chemotherapeutic Agents in Cancer Therapy” |
Shwu-Huey Liu, Zaoli Jiang, Tah-Mun Su, Wen-Yi Gao, Chung-Hang Leung, Yashang Lee and Yung-Chi Cheng
Proc. Am Assoc Cancer Res. 2004; 45:128, #557
Poster |
|
| |
|
“PHY906, a Chinese herbal formulation enhances the therapeutic effect of cancer chemotherapy in human colorectal and liver cancer” |
Shwu-Huey Liu, Zaoli Jiang, Wenli Gao, Yashang Lee, Ginger Dutschman Tahmun Su, Jay Xu, Robert Tilton, Shivaani Kummar, and Yung-Chi Cheng.
Proc. Am Soc Clin Oncol. 2003, #864. |
|
| |
| |
“Scutellaria baicalensis Georgi, a commonly used herb in Chinese medicine, could facilitate oral absorption of drugs and overcome multidrug resistance in cancer caused by P-glycoprotein 170” |
Yashang Lee, Shwu-Huey Liu, Zaoli Jiang and Yung-Chi Cheng
Proc. Am Assoc Cancer Res. 2003; 44:862, #3767 |
|
| |
|
“Developing PHY906 as a modulator in cancer chemotherapy” |
Shwu-Huey Liu
Proceedings of 3rd TWGHS-CUHK Eddie Wang Symposium on Complementary Chinese and Western Medicine Integrated Approach. p. 69 (2002) |
|
| |
|
“Botanical Activity Relationship in Traditional Chinese Medicine: Studies of PHY906 as an Adjuvant Therapy with Cancer Chemotherapeutic Agents” |
Shwu-Huey Liu, Zaoli Jiang and Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2002; 43:961, #4758.
Poster |
|
| |
|
“A Chinese Medicine Formulation, PHY-906, Can Enhance The Therapeutic Index of CPT-11 and Other Anticancer Drugs Against Cancer in Mice” |
Liu, Shwu-Huey; Jiang, Zaoli; Cheng, Yung-Chi
Proc. Am Assoc Cancer Res. 2001; 42:85, 458.
Poster |
|
| |
|
“Using Modern Technology in Developing a Chinese Herbal Medicine” |
Shwu-Huey Liu, Zaoli Jiang, Jim Liddil, Elizabeth A. Gullen and Yung-Chi Cheng.
Proceedings of The Third Symposium on Herbal Medicine: Taking Herbal Medicine into the Global Mainstream Healthcare System in the 21th Century. P. 39 (2000) |
|
| |
|
“Prevention of CPT-11 Induced Toxicity by a Chinese Medicinal Formulation, PHY-906” |
Shwu-Huey Liu, Z. Jiang, J Liddil, K. Hu, E. A. Gullen and Yung-Chi Cheng.
Proc. Am Assoc Cancer Res. 2000; 41:410, 2608.
Poster |
|
| |
| |
| |
|